View Clinical Trial (Medical Research Study)

Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis - NCT00884585-(Clinical Trial 287894)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Bakersfield
State:  
CA
Zip Code:
Conditions: Atopic Conjunctivitis
Purpose: This study evaluates the efficacy and safety of Cyclosporine 0.010% eye drops in the treatment of Atopic Keratoconjunctivitis (chronic and severe inflammation of the eye). The study consists of a double-masked phase, and open-labeled phase, and an open-labeled maintenance phase. For the first 3 months of the study, patients will receive either masked Cyclosporine 0.010% eye drops or vehicle four times daily; for the next 6 months, patients may receive open-labeled Cyclosporine 0.010% eye drops four times daily. At month 9, patients who are in remission, will be re-randomized to receive either open-labeled Cyclosporine 0.010% eye drops four times daily or twice daily
Study summary:
Criteria: Inclusion Criteria: - Have a clinical diagnosis of Atopic Keratoconjunctivitis (chronic and severe inflammation of the eye) - Be on stable doses of your current AKC medications for at least 2 weeks Exclusion Criteria: - You have used contact lenses within 48 hours of Day 1 or think you may have to wear contact lenses during the study - You are pregnant, breastfeeding, or planning to become pregnant during the study - You have used a calcineurin inhibitors (e.g. topical tacrolimus or topical pimecrolimus) on or around your eyes including eyelids within 4 weeks
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: August 3, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.